Sort by
Items per page

Send to

Choose Destination

Search results

Items: 6


Sexual function and chemotherapy in postmenopausal women with breast cancer.

Cavalheiro JA, Bittelbrunn A, Menke CH, Biazús JV, Xavier NL, Cericatto R, Schuh F, Pinheiro CV, Passos EP.

BMC Womens Health. 2012 Sep 11;12:28.


[Intraoperative injection of technetium-99m-dextran 500 for the identification of sentinel lymph node in breast cancer].

Delazeri GJ, Xavier NL, Menke CH, Bittelbrunn AC, Spiro BL, Mosmann MP, Graudenz MS.

Rev Bras Ginecol Obstet. 2010 Oct;32(10):486-90. Portuguese.


Prevalence of vascular-endothelial growth factor, matrix metalloproteinases and tissue inhibitors of metalloproteinases in primary breast cancer.

Jobim FC, Xavier NL, Uchoa DM, Cruz DB, Saciloto M, Chemello N, Schwartsmann G.

Braz J Med Biol Res. 2009 Oct;42(10):979-87. Epub 2009 Sep 4.


[Expression of MMP-9 and VEGF in breast cancer: correlation with other prognostic indicators].

Jobim FC, Schwartsmann G, Xavier NL, Uchoa Dde M, Saciloto M, Chemello N.

Rev Bras Ginecol Obstet. 2008 Jun;30(6):287-93. Portuguese.


Scintigraphic sentinel node detection in breast cancer patients: paired and blinded comparison of 99mTc dextran 500 and 99mTc phytate.

Masiero PR, Xavier NL, Spiro BL, Detanico MF, Xavier Mda C, Pinto AL.

Nucl Med Commun. 2005 Dec;26(12):1087-91.


Sentinel lymph node identification and sampling in women with early breast cancer using 99m Tc labelled dextran 500 and patent blue V dye.

Xavier NL, Amaral BB, Cerski CT, Fuchs SC, Spiro BL, Oliveira OL, Menke CH, Biazús JV, Cavalheiro JA, Schwartsmann G.

Nucl Med Commun. 2001 Oct;22(10):1109-17.


Supplemental Content

Loading ...
Support Center